Deep Brain Stimulation (DBS) of the Globus pallidus (GP) in Huntington's disease (HD): A prospective, randomized, controlled, multi-centre study
Deep Brain Stimulation (DBS) of the Globus pallidus (GP) in Huntington's disease (HD): A prospective, randomized, controlled, multi-centre study
批准号:
223201247
负责人:
Professor Dr. Jan Vesper
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Clinical Trials
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2021-12-31
中文摘要
有大量证据表明,深部脑刺激可成功地对症治疗其他运动障碍,但仅有少数病例报道深部脑刺激治疗亨廷顿S病(HD)。因此,DBS在一项针对HD症状治疗的前瞻性试点试验中进行了评估。根据我们的试点试验结果,有证据表明,苍白球的DBS显著改善了HD患者的舞蹈症状。它对UHDR总量也有积极影响。因此,这项前瞻性多中心试验旨在以假刺激对照设计证明苍白球DBS在44例HD患者中的短期和长期疗效和安全性。这项研究的重点是对生活质量(QOL)和运动改善的潜在影响。主要终点将是从基线到术后12周的UHDRS变化(对照组不进行刺激,马鞭组进行刺激)。此外,将在术后12周进行一系列运动评分、定量运动测量、认知和精神评估以及生活质量问卷调查。对这些评分的长期影响将在接下来的非盲法3个月阶段(术后6个月的次要终点)进行评估。将对UHDRS和副作用(AE)进行长达12个月的开放式随访。计划中的临床试验进一步为额外资助的神经生理学研究开辟了前景,以探索HD患者脑深部刺激的机制。
英文摘要
There is high level of evidence for deep brain stimulation (DBS) for successful symptomatic treatment of other movement disorders but only a few case reports of DBS in Huntington´s Disease (HD). Thus, DBS was evaluated in a prospective pilot trial for the symptomatic treatment of HD. Based on our pilot trial results there is evidence, that DBS of the pallidum significantly improves especially choreatic symptoms in HD. It also has positive influence on total UHDRS. Therefore this prospective multi-centre trial aims at proving the short and long-term efficacy and safety of pallidal DBS in 44 HD patients in a sham-stimulation controlled design. The study focuses on potential influence on Quality of life (QOL) and motoric improvement. Primary endpoint will be the UHDRS change from baseline to 12 weeks postoperatively (control group off stimulation vs. verum group on stimulation). Furthermore there will be a battery of motor scores, quantitative motor measurements, cognitive and psychiatric evaluations and questionnaires for QOL at 12 weeks postoperatively. Long-term effects on these scores will be evaluated in the following unblinded 3 months phase (secondary endpoint 6 months postoperatively). An open follow-up up to 12 months will be assessed for UHDRS and side effects (AE). The planned clinical trial furthermore opens perspective for additional funded neurophysiological studies to explore mechanisms of deep brain stimulation in patients with HD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
-
批准号:81801389
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:田茗源
-
依托单位:
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
-
批准号:81101046
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:黄静
-
依托单位: